Dessi McEntee, MS, DABT

Dessi McEntee, MS, DABT has over 10 years of experience in the field of toxicology. Dessi began their career in 2012 at Pfizer as an In Vivo Study Scientist. In 2018, they moved to Instem as a Senior Information Scientist. In 2021, they joined Epizyme as a Nonclinical Safety Study Manager and Operations Lead. Currently, they are working at Q32 Bio Inc. as an Associate Director of Toxicology and at Toxistrategy LLC as a Founder/Consultant.

Dessi McEntee, MS, DABT has a diverse educational background. Dessi received their Bachelor's degree from the University of Connecticut in Animal Sciences in 2012. Dessi then went on to receive their Master of Science in Pharmacology and Toxicology from Michigan State University in 2018. Currently, they are pursuing their Master of Business Administration - MBA at LSU Shreveport and is expected to graduate in 2024. Additionally, they hold certifications from the American Board of Toxicology, Inc., the American College of Toxicology (ACT), Pfizer, and AALAS.